XML 96 R45.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Share-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Compensation [Abstract] |
Schedule of Company Granted Options | In the years ended December 31, 2024, and 2023, the Company granted options as follows:
|  | Year ended December 31, 2024 |
|  | Award amount |  |  | Exercise price |  |  | Vesting period |  |  | Expiration |
Employees |  |  | 65,957 |  |  |  | 0.23 NIS |  |  |  | 4 years |  |  |  | 10 years |
Employees |  |  | 378,901 |  |  |  | $9.44-$10.88 |  |  |  | 4 years |  |  |  | 10 years |
Directors |  |  | 75,957 |  |  |  | 0.23 NIS |  |  |  | 4 years |  |  |  | 10 years |
Subcontractors |  |  | 4,390 |  |  |  | 0.23 NIS |  |  |  | 4 years |  |  |  | 10 years |
Subcontractors |  |  | 16,834 |  |  |  | $9.67-$10.48 |  |  |  | 4 years |  |  |  | 10 years |
Total granted |  |  | 542,039 |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Year ended December 31, 2023 |
|  | Award amount |  |  | Exercise price |  |  | Vesting period |  |  | Expiration |
Employees |  |  | 339,185 |  |  |  | 0.23 NIS |  |  |  | 4 years |  |  |  | 10 years |
Subcontractors and directors |  |  | 4,997 |  |  |  | 0.23 NIS |  |  |  | 4 years |  |  |  | 10 years |
Total granted |  |  | 344,182 |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Fair Value of the Options | The underlying data used for computing the fair value of the options (as of the grant date) are as follows:
|  | 2024 |  |  | 2023 |
Employees |  |  |  |  |  |  |  |
Expected term (years) — |  |  | 6.11 |  |  |  | 5.91-6.14 |
Expected volatility |  |  | 43.48 | % |  |  | 40.98% - 42.14 | %
Risk free interest rate |  |  | 4.30 | % |  |  | 3.80%-3.83 | %
Expected dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Exercise price |  |  | 0.06-10.48 |  |  |  | 0.06 |
Non-Employees |  |  |  |  |  |  |  |
Expected term (years) — |  |  | 10.00 |  |  |  | 10.00 |
Expected volatility |  |  | 43.48 | % |  |  | 42.09%-42.17 | %
Risk free interest rate |  |  | 4.30 | % |  |  | 3.64%-3.75 | %
Expected dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Exercise price |  |  | 0.06-10.48 |  |  |  | 0.06 |
Assumptions regarding the price of the underlying shares: |  |  |  |  |  |  |  |
Probability of an IPO |  |  | 30 | % |  |  | 25 | %
Expected time to IPO (years) |  |  | 0.5 |  |  |  | 0.75 |
Probability of liquidation event |  |  | 70 | % |  |  | 75 | %
Expected time to liquidation (years) |  |  | 2.0 |  |  |  | 2.0 |
Schedule of Outstanding and Exercisable Options | The following table summarizes the number of options outstanding for the years ended December 31, 2024 and December 31, 2023, and related information:
|  | Number of options |  |  | Weighted- average exercise price |  |  | Weighted- average remaining contractual term (in years) |  |  | Aggregate Intrinsic Value (in U.S. dollars) |
Outstanding at December 31, 2023 |  |  | 1,300,475 |  |  | $ | 0.066 |  |  |  | 7.75 |  |  | $ | 14,109 |
Granted |  |  | 542,039 |  |  | $ | 7.667 |  |  |  | 9.85 |  |  | $ | - |
Exercised |  |  | (186,038 | ) |  | $ | 0.062 |  |  |  | (6.82 | ) |  | $ | 1,508 |
Forfeited |  |  | (23,684 | ) |  | $ | 4.466 |  |  |  | (8.86 | ) |  | $ | - |
Expired |  |  | (2,219 | ) |  | $ | 0.065 |  |  |  |  |  |  | $ | - |
Outstanding at December 31, 2024 |  |  | 1,630,573 |  |  | $ | 2.5259 |  |  |  | 7.63 |  |  | $ | 12,274 |
Exercisable at December 31, 2024 |  |  | 947,700 |  |  | $ | 0.518 |  |  |  | 6.67 |  |  | $ | 8,938 |
Vested and expected to vest at December 31, 2024 |  |  | 1,630,573 |  |  | $ | 2.529 |  |  |  | 7.63 |  |  | $ | 12,274 |
|  | Number of options |  |  | Weighted- average exercise price |  |  | Weighted- average remaining contractual term (in years) |  |  | Aggregate Intrinsic Value (in U.S. dollars) |
Outstanding at December 31, 2022 |  |  | 1,008,927 |  |  | $ | 0.068 |  |  |  | 8.12 |  |  | $ | 9,601 |
Granted |  |  | 344,182 |  |  | $ | 0.063 |  |  |  | 9.80 |  |  | $ | - |
Exercised |  |  | (23,254 | ) |  | $ | 0.062 |  |  |  | (7.10 | ) |  | $ | 224 |
Forfeited |  |  | (24,374 | ) |  | $ | 0.067 |  |  |  | (8.91 | ) |  | $ | - |
Expired |  |  | (5,006 | ) |  | $ | 0.070 |  |  |  | - |  |  | $ | - |
Outstanding at December 31, 2023 |  |  | 1,300,475 |  |  | $ | 0.066 |  |  |  | 7.75 |  |  | $ | 14,109 |
Exercisable at December 31, 2023 |  |  | 818,625 |  |  | $ | 0.067 |  |  |  | 7.28 |  |  | $ | 8,881 |
Vested and expected to vest at December 31, 2023 |  |  | 1,300,475 |  |  | $ | 0.066 |  |  |  | 7.75 |  |  | $ | 14,109 |
Schedule of Company’s Nonvested Employee Options | The following table summarizes the number of options outstanding for the years ended December 31, 2024 and December 31, 2023, and related information:
|  | Number of options |  |  | Weighted- average grant-date fair value price |
Outstanding at December 31, 2023 |  |  | 481,850 |  |  |  | 9.68 |
Granted |  |  | 542,039 |  |  |  | 13.25 |
Vested |  |  | (317,304 | ) |  |  | 9.99 |
Forfeited |  |  | (23,684 | ) |  |  | 10.83 |
Outstanding at December 31, 2024 |  |  | 682,901 |  |  |  | 12.33 |
Outstanding at December 31, 2022 |  |  | 458,218 |  |  |  | 8.24 |
Granted |  |  | 344,182 |  |  |  | 10.80 |
Vested |  |  | (296,176 | ) |  |  | 8.76 |
Forfeited |  |  | (24,374 | ) |  |  | 9.53 |
Outstanding at December 31, 2023 |  |  | 481,850 |  |  |  | 9.68 |
Schedule of Consolidated Statements of Operations | The share-based compensation expense by line item in the accompanying consolidated statements of operations is summarized as follows:
|  | Year ended December 31 |
|  | 2024 |  |  | 2023 |
Cost of sales |  | $ | 303 |  |  | $ | 139 |
Research and development |  |  | 610 |  |  |  | 240 |
General and administrative |  |  | 4,975 |  |  |  | 1,964 |
Sales and marketing |  |  | 719 |  |  |  | 224 |
|  | $ | 6,607 |  |  | $ | 2,567 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(1) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(1) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration